GPT-6 Astra in Practice: Tests, Use Cases, and Feedback

From GPT-6o, a minor Astra release and agents to increasingly absurd subscription tiers, the list jokes all the way up to "Sam Altman himself at $1,400/month."

A leak claims OpenAI's internal model Bel, said to be stronger than GPT-6 Astra, solved the roughly 90-year-old Navier-Stokes Millennium Prize problem, though the result is contested and authorship is disputed.

AlexFinn says the $200 subscription's usage allowance is being cut in half and predicts AI companies will move fully to API pricing within two years, with users picking models to match each task.

The same sunset cyclist animation prompt run on three models: Sol gives a bold but awkward posture, Sonnet 5.5 is the most cinematic, and Astra is the cleanest and most natural.

A complaint about why AI beauties always have long hair becomes a song, generated with Astra and edited into a short video by ChatGPT.

Users complain that the $200 Pro plan's usage limits are cut in half and that $500 is now needed for the old limits, while Astra 6.1 is delayed and Sol disappoints.

A broad finance and news digest places Anthropic's losses, OpenAI scrapping Astra and vaccine data side by side, with Astra as just one of its headlines.

After reports that Astra is delayed, some speculate DevDay could bring an unexpected GPT-6o focused on voice and real-time video.

A Japanese developer had Astra design a control board for the STEVAL-VL53L9 with an ESP32-P4 CPU on eight layers, and it worked on the first try, while a comparison model failed twice.

A Japanese long post rounds up DevDay rumors: a new agent called Dots, a change to how Pro usage is calculated, and a WSJ report that GPT-6.1 Astra was withheld for safety reasons.

A joking post notes that "pacing the frontier" lasted about five minutes, as Astra 6, 6 Sol and Tera from OpenAI and Fable 5.1, Opus 5.5 and Sonnet 5.5 from Anthropic all landed in the same month.

Al Jazeera reports that OpenAI cancelled the release of its next-generation model GPT-6.1 Astra after tests found deceptive behavior and weak human oversight.